You have searched for "biomedical"
Showing 1-10 of 574
ROME, Nov. 26 (Xinhua) -- The coronavirus mortality rate in Italy continued to climb while the rate of new infections inched lower, though health experts warned against relaxing restrictions.
GOING to university is a big step – this period in a young adult’s life certainly meets with some excitement and unease.
RIO DE JANEIRO (Reuters) - Brazil surpassed 6 million confirmed cases of COVID-19 on Friday, the health ministry said, as the world's third-worst coronavirus outbreak begins to surge again amid fears that a second wave is underway.
SINGAPORE/BEIJING (Reuters) - Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.
News Analysis: "A marathon, not a sprint" -- Italy's anti-virus rules depend on personal responsibility
ROME, Nov. 16 (Xinhua) -- Italian government health restrictions to confront the second wave of the coronavirus rely on increased levels of personal responsibility, health officials and experts said.
(Reuters) - Moderna Inc became the second U.S company to release data from a large study of its experimental vaccine, saying it was 94.5% effective against COVID-19.
(Reuters) - Johnson & Johnson and the U.S. Department of Health and Human Services have expanded an agreement to support the next phase of COVID-19 vaccine candidate research and development, the company said on Saturday.
BRUSSELS (Reuters) - The European Commission on Wednesday proposed an overhaul of the rules on public health which would give the EU the power to declare an health emergency and stress test national plans to tackle pandemics.
PUTRAJAYA: Local television channel TV3 has apologised over a news report that erroneously called United States vice president-elect Kamala Harris the daughter of an illegal immigrant.
WASHINGTON/WILMINGTON, Del. (Reuters) - President-elect Joe Biden will convene a coronavirus task force on Monday to examine the No. 1 problem confronting him when he takes office in January, while President Donald Trump pursues several long-shot gambits to hold on to his job.